Influence of the COVID-19 Pandemic on Treatment Times for Acute Ischemic Stroke
Authors:
- James E. SieglerJSJames E. Siegler
- Alicia M. ZhaAZAlicia M. Zha
- Alexandra L. CzapACAlexandra L. Czap
- Santiago Ortega-GutierrezSOSantiago Ortega-Gutierrez
- Mudassir FarooquiMFMudassir Farooqui
- David S. LiebeskindDLDavid S. Liebeskind
- Shashvat M. DesaiSDShashvat M. Desai
- Ameer E. HassanAHAmeer E. Hassan
- Amy K. StarosciakASAmy K. Starosciak
- Italo LinfanteILItalo Linfante
- Vivek RaiVRVivek Rai
- Jesse M. ThonJTJesse M. Thon
- 1 January 2021
- journal article
- research article
- Published by Wolters Kluwer Health in Stroke
- Vol. 52 (1) , 40-47
Abstract
Background and Purpose: The pandemic caused by the novel coronavirus disease 2019 (COVID-19) has led to an unprecedented paradigm shift in medical care. We sought to evaluate whether the COVID-19 pandemic may have contributed to delays in acute stroke management at comprehensive stroke centers. Methods: Pooled clinical data of consecutive adult stroke patients from 14 US comprehensive stroke centers (January 1, 2019, to July 31, 2020) were queried. The rate of thrombolysis for nontransferred patients within the Target: Stroke goal of 60 minutes was compared between patients admitted from March 1, 2019, and July 31, 2019 (pre–COVID-19), and March 1, 2020, to July 31, 2020 (COVID-19). The time from arrival to imaging and treatment with thrombolysis or thrombectomy, as continuous variables, were also assessed. Results: Of the 2955 patients who met inclusion criteria, 1491 were admitted during the pre–COVID-19 period and 1464 were admitted during COVID-19, 15% of whom underwent intravenous thrombolysis. Patients treated during COVID-19 were at lower odds of receiving thrombolysis within 60 minutes of arrival (odds ratio, 0.61 [95% CI, 0.38–0.98]; P =0.04), with a median delay in door-to-needle time of 4 minutes ( P =0.03). The lower odds of achieving treatment in the Target: Stroke goal persisted after adjustment for all variables associated with earlier treatment (adjusted odds ratio, 0.55 [95% CI, 0.35–0.85]; P P =0.02). There was no significant delay in door-to-groin puncture for patients who underwent thrombectomy (median, 83 [interquartile range, 63–133] versus 90 [interquartile range, 73–129] minutes; P =0.30). Delays in thrombolysis were observed in the months of June and July. Conclusions: Evaluation for acute ischemic stroke during the COVID-19 period was associated with a small but significant delay in intravenous thrombolysis but no significant delay in thrombectomy time metrics. Taking steps to reduce delays from imaging to bolus time has the potential to attenuate this collateral effect of the pandemic.Keywords
This publication has 27 references indexed in Scilit:
- Governmental Public Health Powers During the COVID-19 PandemicJAMA, 2020
- Temporary Emergency Guidance to US Stroke Centers During the Coronavirus Disease 2019 (COVID-19) PandemicStroke, 2020
- An interactive web-based dashboard to track COVID-19 in real timeThe Lancet Infectious Diseases, 2020
- Personal protective equipment during the coronavirus disease (COVID) 2019 pandemic – a narrative reviewAnaesthesia, 2020
- Use of Emergency Medical Services and Timely Treatment Among Ischemic StrokeStroke, 2019
- Patterns of Emergency Medical Services Use and Its Association With Timely Stroke TreatmentCirculation: Cardiovascular Quality and Outcomes, 2013
- Higher volume endovascular stroke centers have faster times to treatment, higher reperfusion rates and higher rates of good clinical outcomesJournal of NeuroInterventional Surgery, 2012
- Diagnosis and treatment of patients with stroke in a mobile stroke unit versus in hospital: a randomised controlled trialThe Lancet Neurology, 2012
- Improving Door-to-Needle Times in Acute Ischemic StrokeStroke, 2011
- Seasonal variation in stroke mortality ratesNeurology, 1999